OR5BN1P

Across TCGA pan-cancer cohorts, OR5BN1P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR5BN1P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR5BN1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5BN1P expression acts as an unfavorable survival marker.

STAD, UCEC, and KIRP are the cancer types where OR5BN1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.247	0.716	.002	45	view →
UCEC	DFS	Tertile	All	0.814	0.898	.015	36	view →
KIRP	OS	Tertile	All	0.199	0.903	<.001	36	view →
SKCM	DFS	Tertile	All	0.257	0.728	.042	18	view →
BLCA	DFS	Tertile	III,IV	0.180	0.574	.015	18	view →
LAML	DFS	Tertile	All	0.028	0.583	.001	18	view →
BRCA	OS	Tertile	II,III,IV	0.138	0.565	.013	12	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR5BN1P–STAD (OS)

Open the STAD breakdown →